臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

关于TAIR
	计画说明

浏览
	典藏机构
	作者
	题名
	日期
	统计图表
	机构即时统计
	学术趋势

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作权
	出版社及期刊政策查询
	TAIR著作权会议记录

相关连结
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"jen chang ko"的相关文件

回到依作者浏览
依题名排序	依日期排序

显示项目 116-140 / 290 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构	日期	题名	作者
臺大學術典藏	2021-03-11T08:34:22Z	Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilities	Lee M.-R.;Tsai C.-J.;Hu J.-Y.;Lee S.-W.;Jen-Chang Ko;Wang H.-C.;Yu C.-J.;Lee L.-N.;Hsueh P.-R.; MENG-RUI LEE; Chia-Jung Tsai; Jia-Ying Hu; Shih-Wei Lee; JEN-CHANG KO; Hao-Chien Wang; Chong-Jen Yu; Li-Na Lee; Po-Ren Hsueh
臺大學術典藏	2021-03-11T08:34:22Z	Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells	Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏	2021-03-11T08:34:22Z	Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells	Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏	2021-03-11T08:34:21Z	Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis	Lee M.-R.;Huang Y.-P.;Kuo Y.-T.;Luo C.-H.;Shih Y.-J.;Shu C.-C.;Wang J.-Y.;Jen-Chang Ko;Yu C.-J.;Lin H.-H.; MENG-RUI LEE; Ya-Ping Huang; Yu-Ting Kuo; Chen-Hao Luo; Yun-Ju Shih; Chin-Chung Shu; Jann-Yuan Wang; JEN-CHANG KO; Chong-Jen Yu; Hsien-Ho Lin
臺大學術典藏	2021-03-11T08:34:21Z	Diabetes Mellitus and Latent Tuberculosis Infection: A Systemic Review and Metaanalysis	Lee M.-R.;Huang Y.-P.;Kuo Y.-T.;Luo C.-H.;Shih Y.-J.;Shu C.-C.;Wang J.-Y.;Jen-Chang Ko;Yu C.-J.;Lin H.-H.; MENG-RUI LEE; Ya-Ping Huang; Yu-Ting Kuo; Chen-Hao Luo; Yun-Ju Shih; Chin-Chung Shu; Jann-Yuan Wang; JEN-CHANG KO; Chong-Jen Yu; Hsien-Ho Lin
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:21Z	Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma	Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:21Z	Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression	Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:21Z	Salinomycin enhances cisplatin-induced cytotoxicity in human lung cancer cells via down-regulation of AKT-dependent thymidylate synthase expression	Jen-Chang Ko;Zheng H.-Y.;Chen W.-C.;Peng Y.-S.;Wu C.-H.;Wei C.-L.;Chen J.-C.;Lin Y.-W.; JEN-CHANG KO; Zheng H.-Y.; Chen W.-C.; Peng Y.-S.; Wu C.-H.; Wei C.-L.; Chen J.-C.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:20Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏	2021-03-11T08:34:20Z	Tuberculosis contact investigation in an intermediate burden setting: implications from a large tuberculosis contact cohort in Taiwan	Lee M.-R.;Ho C.-M.;Lee C.-H.;Lee M.-C.;Chang L.-Y.;Yu K.-L.;Jen-Chang Ko;Wang J.-Y.;Wang J.-T.;Lee L.-N.; MENG-RUI LEE; Cheng-Maw Ho; Chih-Hsin Lee; Ming-Chia Lee; LIH-YU CHANG; KAI-LUN YU; JEN-CHANG KO; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Gefitinib or erlotinib in previously treated non–small-cell lung cancer patients: a cohort study in Taiwan	Chang C.-H.;Lee C.-H.;Jen-Chang Ko;Chang L.-Y.;Lee M.-C.;Wang J.-Y.;Yu C.-J.; CHIA-HAO CHANG; Chih-Hsin Lee; JEN-CHANG KO; LIH-YU CHANG; Ming-Chia Lee; Jann-Yuan Wang; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:20Z	Cementing an unwanted relationship	Chang C.-H.;Keng L.-T.;Jen-Chang Ko; CHIA-HAO CHANG; LI-TA KENG; JEN-CHANG KO
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study	Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Psychological distress and coping strategies among women with incurable lung cancer: a qualitative study	Liao Y.-C.;Liao W.-Y.;Sun J.-L.;Jen-Chang Ko;Yu C.-J.; Liao Y.-C.; Liao W.-Y.; Sun J.-L.; JEN-CHANG KO; Chong-Jen Yu
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:19Z	Factors associated with improvement in symptoms and quality of life for first-line EGFR-tyrosine kinase inhibitor treatment in patients with EGFR-mutated non-small-cell lung cancer - A multicenter prospective SMILE study	Wei Y.-F.;Huang W.-T.;Liu T.-C.;Shieh J.-M.;Chian C.-F.;Wu M.-F.;Chang C.-C.;Lin C.-H.;Jen-Chang Ko;Lin C.-M.;Hsia T.-C.; Wei Y.-F.; Huang W.-T.; Liu T.-C.; Shieh J.-M.; Chian C.-F.; Wu M.-F.; Chang C.-C.; Lin C.-H.; JEN-CHANG KO; Lin C.-M.; Hsia T.-C.
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations	Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.
臺大學術典藏	2021-03-11T08:34:18Z	Inhibition of thymidine phosphorylase expression by Hsp90 inhibitor potentiates the cytotoxic effect of salinomycin in human non-small-cell lung cancer cells	Jen-Chang Ko;Chen J.-C.;Chen T.-Y.;Yen T.-C.;Ma P.-F.;Lin Y.-C.;Wu C.-H.;Peng Y.-S.;Zheng H.-Y.;Lin Y.-W.; JEN-CHANG KO; Chen J.-C.; Chen T.-Y.; Yen T.-C.; Ma P.-F.; Lin Y.-C.; Wu C.-H.; Peng Y.-S.; Zheng H.-Y.; Lin Y.-W.

显示项目 116-140 / 290 (共12页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

	English \| 正體中文 \| 简体中文 \| 总笔数 :0
	造访人次 : 51929747 在线人数 : 1144 教育部委托研究计画计画执行:国立台湾大学图书馆